Breaking News, Promotions & Moves

Jazz Pharmaceuticals Names Renee Gala as President & CEO

Gala brings more than 30 years of experience across finance, strategy, corporate development, and commercialization.

Author Image

By: Charlie Sternberg

Associate Editor

Jazz Pharmaceuticals’ Board of Directors has unanimously selected Renee Gala, Jazz’s President and Chief Operating Officer, as President and Chief Executive Officer, effective August 11, 2025. She will succeed co-founder, Chairperson and CEO Bruce Cozadd, who informed the Board in December 2024 of his intent to retire as CEO upon the identification of the Company’s next leader. This appointment reflects a key milestone in the Board’s long-term succession planning process and...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters